| 1-MT | 1-methyltryptophan |
| 3-HAAO | 3-hydoxyanthranillic acid dioxygenase |
| 3-HK | 3-Hydroxykynurenine |
| α7nAChR | Alpha-7-nicotinic acetylcholine receptor |
| AβPP/PS | double transgenic mice expressing a chimeric mouse/human amyloid precursor protein (Mo/HuAPP695swe) and a mutant human presenilin 1 (PS1-dE9) |
| ACMSD | 2-Amino-3-carboxymuconic-6-semiladehyde decarboxylase |
| AD | Alzheimer’s disease |
| AhR | Aryl hydrocarbon receptor |
| BBB | blood–brain barrier |
| CA | Cinnabarinic acid |
| CA1 | Cornu Ammonis 1 |
| CNS | Central nervous system |
| COX2 | Cyclooxygenase 2 |
| CSF | Cerebrospinal fluid |
| FCMTE | Familial cortical myoclonic tremor with epilepsy |
| GlyB | Glycine B Site |
| GPR35 | G-protein couples receptor 35 |
| GWAS | Genome Wide Association Studies |
| HD | Huntington’s disease |
| HIV | Human immunodeficiency virus |
| ICV | Intracerebroventricular |
| IDO | Indoleamine-2,3-dioxygenase |
| KAT | Kynurenine aminotransferase |
| KA | Kynurenic acid |
| KAT | Kynurenine aminotransferase |
| Kyn | Kynurenine |
| KMO | Kynurenine-3-monooxygenase |
| KP | kynurenine Pathway |
| LAT1 | Large amino acid transporter 1 |
| LPS | Lipopolysaccharide |
| LTP | Long term potentiation |
| MDD | Major depressive disorder |
| mGLUR | Metabotropic glutamate receptors |
| MPTP | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| NAD | Nicotinamide adenine dinucleotide |
| NMDAR | N-methyl-D-aspartate receptor |
| PD | Parkinson’s disease |
| PA | Picolinic acid |
| PDD | Postpartum depression |
| QA | Quinolinic acid |
| SBI | Surgical brain injury |
| SNI | Spared nerve injury |
| SNP | Single nucleotide polymorphism |
| SNRI | Selective norepinephrine reuptake inhibitor |
| SSRI | Selective serotonin reuptake inhibitor |
| TCA | Tricyclic antidepressants |
| TDO | Tryptophan-2,3-dioxygnease |
| TRD | Treatment resistant depression |
| TRP | Tryptophan |
| VGLUT | Vesicle glutamate transporter |